Tirz (20mg)
$199.00
Tirzepatide (Tirz) is a dual GIP and GLP-1 receptor agonist being studied for its role in glucose regulation and weight management. Research suggests it may improve insulin sensitivity, lower blood sugar levels, and support significant weight loss, making it of interest in diabetes and obesity studies.
This product is for research purposes only and is not intended for human or animal use. Dosing information cannot be provided, but all products are of pharmaceutical-grade quality. All products are supplied in lyophilized powdered form and must be mixed with Bacteriostatic Water to convert them into a liquid form for research and testing.
Category: Metabolic Research
Reviews
There are no reviews yet.